Skip to content
10-Q

Quarterly Report

KODIAK SCIENCES INC. KOD

0000950170-25-071523

← back to feed
Filed
May 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 7, 2025 52.76M sh
Current Liabilities Q1 2025 · Mar 31, 2025 $30.88M
Current Liabilities Q1 2025 · Dec 31, 2024 $25.57M
Total Liabilities Q1 2025 · Mar 31, 2025 $189.07M
Total Liabilities Q1 2025 · Dec 31, 2024 $185.29M
Current Assets Q1 2025 · Mar 31, 2025 $142.69M
Current Assets Q1 2025 · Dec 31, 2024 $171.94M
Total Assets Q1 2025 · Mar 31, 2025 $297.91M
Total Assets Q1 2025 · Dec 31, 2024 $335.58M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $168.07M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $245.92M
Shares Diluted Q1 2025 · Mar 31, 2024 52.51M sh
Capex Q1 2025 · Mar 31, 2024 $22K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$39.6M
Stockholders Equity Q1 2025 · Mar 31, 2024 $241.19M
Stockholders Equity Q1 2025 · Dec 31, 2023 $265.78M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.82
Eps Basic Q1 2025 · Mar 31, 2024 −$0.82
Sga Expense Q1 2025 · Mar 31, 2024 $16.12M
Rd Expense Q1 2025 · Mar 31, 2024 $29.93M
Net Income Q1 2025 · Mar 31, 2024 −$43.04M
Operating Income Q1 2025 · Mar 31, 2024 −$46.06M